Maxime Dely – Simple Transfusion or Red Cell Exchange: Two Techniques, Two Philosophies of Care
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, posted on LinkedIn:
”Simple transfusion or red cell exchange: two techniques, two philosophies of care.
When we think of a blood transfusion, we usually imagine a straightforward act – giving red blood cells to correct anemia or improve oxygenation.
But in certain cases – sickle cell disease, polycythemia vera, severe malaria, or intoxications – there’s another option: red cell exchange by apheresis.
Instead of adding more blood, we gradually replace the patient’s red cells with healthy donor cells using an apheresis machine.
The total blood volume remains constant, and the process is precise, controlled, and personalized for each patient.
The benefits are clear:
- Rapid correction of abnormal red cell proportions.
- No iron overload – a common issue with repeated transfusions.
- Improved blood viscosity, reducing vaso-occlusive risks.
- Above all, a tailored, patient-specific approach – precision transfusion medicine.
Of course, this technique requires specialized expertise, equipment, and teamwork. But it represents where medicine is heading: more targeted, safer, and more human.
Behind every red cell exchange stands a dedicated team – nurses, physicians, and biologists – turning advanced technology into meaningful care.”

Keep up with Hemostasis Today.
-
Dec 18, 2025, 17:13Daria Camilli on EuroBloodNet and EHC Collaboration for Bleeding Disorders
-
Dec 18, 2025, 16:50Marie Cambot on Innovhem’s Quantification of The HbF/HbS Ratio for SCD
-
Dec 18, 2025, 16:26Yogesh Rathod on Hematological Issues and ICU
-
Dec 18, 2025, 16:09Carlos Doti: I’m Reminded Why ASH is Such a Powerful Close to The Year
-
Dec 18, 2025, 15:23Michael Hadley: Well-Timed ACC Statement Just Out in JACC Journals
-
Dec 18, 2025, 15:12Wolfgang Miesbach on Insights from Guy Young’s ASH2025 Session on Next-Generation Gene Therapy
-
Dec 18, 2025, 14:15Plasma-Derived Therapy for Hemophilia in The Updated European Medicines Agency’s Union List
-
Dec 18, 2025, 13:55Laurent Bertoletti: BAT-VTE is One of 7 Projects Funded Under the EFFECT Trial Call!
-
Dec 18, 2025, 13:34Alexandru Stieber Explores VEXAS Syndrome
